


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
LLY
Eli Lilly and
$955.31

Login to see Eli Lilly and (LLY) Stock IQ rating
Get instant clarity on whether to Buy, Hold, or Avoid.
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value

Outperform the market
LLY Price Performance
$985.08 (-3.02%)
$1073.29 (-10.99%)
$1024.95 (-6.79%)
$884.54 (+8.00%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Earnings increase YoY
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Investors confidence is positive
Future
Future
Earnings are forecast to grow
Trading below its fair value
Outperform the market
LLY Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
LLY Street Sentiment is extremely bullish and have positive views on the near-term outlook
LLY has Low risk level
Sentiments overview associated with events and the stock performance
Average key support and resistance price levels
Recent Upgrades and Downgrades
Mar 31, 2026
Reiterate
Overweight
Barclays
Mar 25, 2026
Reiterate
Overweight
Morgan Stanley
Mar 06, 2026
Reiterate
Buy
Deutsche Bank
Feb 13, 2026
Upgrade
Buy
Freedom Capital
Jan 09, 2026
Initiate
Buy
UBS
NVO
Novo Nordisk A/S
37.45
-0.48%
PFE
Pfizer
27.21
-0.96%
ABBV
AbbVie
212.38
+0.36%
SNY
Sanofi
47.14
-0.15%
AZN
Astrazeneca
205.04
+0.32%
What is LLY current stock price?
What are LLY stock strengths?
What is LLY Risk Level?
What is LLY market cap and volume?
What is LLY current Stock IQ?
Should I buy LLY stock right now?
Is LLY a Strong Buy right now?
What does a 'Strong Buy' rating mean for LLY?
What does a 'Strong Sell' rating mean for LLY?
What factors influence LLY's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
LLY
Eli Lilly and
Current Price
$955.31
Runners Also Watch
NVO
Novo Nordisk A/S
37.45
-0.48%
PFE
Pfizer
27.21
-0.96%
ABBV
AbbVie
212.38
+0.36%
SNY
Sanofi
47.14
-0.15%
AZN
Astrazeneca
205.04
+0.32%

LLY Price Performance
$985.08 (-3.02%)
$1073.29 (-10.99%)
$1024.95 (-6.79%)
$884.54 (+8.00%)
LLY Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Earnings increase YoY
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Investors confidence is positive
Future
Future
Earnings are forecast to grow
Trading below its fair value
Outperform the market
LLY Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
LLY Street Sentiment is extremely bullish and have positive views on the near-term outlook
LLY has Low risk level
Average key support and resistance price levels
Overall Wall Street Rating
LLY Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value

Outperform the market
LLY Trading Signals
LLY has breaking news: New Product. Eli Lilly Just Launched Its $149 Obesity Pill. Eli Lilly and Co . (NYSE: LLY ) on Wednesday announced that Foundayo (orforglipron) is now availabl...
LLY has breaking news: New Product. Eli Lilly launches new weight loss pill Foundayo in United States....
LLY has breaking news: FDA Approval. Foundayo FDA approval: what changes for patients? #health. Eli Lillys Foundayo (oral GLP 1) expands weight loss options The FDA has approved Eli Lilly...
LLY has breaking news: New Product. WW International Adds Lillys GLP-1 Foundayo To Med Program. (RTTNews) - WW International Inc. (WW) a weight loss solutions provider on Thursday said...
LLY has breaking news: FDA Approval. What is Foundayo and who can use it? #health. FDA approval of Eli Lillys oral weight loss pill Foundayo The FDA approved Eli Lillys new GLP 1 daily pi...
LLY Stock IQ rose from 3.95 to 4.68 today, reflecting an improved outlook.
LLY Stock IQ sentiment changed from Bullish to Strong Bullish, reflecting a changed outlook.
LLY has closed up for 3 consecutive days
LLY is trading 42.77% below analyst target price of $1,363.92, suggesting significant upside potential
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.